This trial is active, not recruiting.

Condition tobacco use cessation
Treatments quitline-delivered proactive telephone counseling, follow-up phone call, smoking cessation training, qualitative interviews concerning the implementation of aac
Sponsor M.D. Anderson Cancer Center
Collaborator Cancer Therapy and Research Center, Texas
Start date April 2013
End date April 2049
Trial size 5212 participants
Trial identifier NCT01788787, 2012-1112, PP12019


The goal of this behavioral research study is to learn about the outcomes of smoking cessation treatment. Researchers want to learn how many smokers stopped smoking after taking part in smoking cessation treatment with the Texas Quitline.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Patients interested in smoking cessation treatment by calling the Texas Quitline.
quitline-delivered proactive telephone counseling
Smokers who enroll in treatment receive standard counseling protocol offered by the Quitline. This includes up to five proactive telephone counseling calls, each designed to provide practical expert support to help smokers develop problem-solving and coping skills, secure social support, and design a plan for successful cessation and long-term abstinence.
follow-up phone call
Six months after enrolling in treatment with the Texas Quitline, an MD Anderson research team member will contact patients to assess their smoking status via telephone.
Medical staff (i.e., medical assistants, licensed vocational nurses, registered nurse and physicians).
smoking cessation training
Medical staff (i.e., medical assistants, licensed vocational nurses, registered nurse and physicians) receive initial face-to-face group training on how to ask patients about their smoking status, advise them to quit, and connect them with the Quitline. The specific content of the session will include information on quitting smoking, how to implement AAC, the effectiveness of telephone counseling for smoking cessation delivered via quitlines, and pharmacotherapies including nicotine replacement.
qualitative interviews concerning the implementation of aac
MD Anderson staff conduct individual in-depth interviews with administrative leadership as well as those medical staff who are authorized to enter patient information into the EMR and are trained in the Ask-Advise-Connect approach. All in-depth interviews will be recorded and transcribed.

Primary Outcomes

Evaluate the Reach of Ask Advise Connect (AAC) Smoking Cessation Program
time frame: 2 years

Secondary Outcomes

Efficacy of Ask Advise Connect (AAC) Smoking Cessation Program
time frame: 6 months

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: 1. 18 years of age or older 2. Self-reported current smoker 3. Present for care at one of the 13 Harris Health System (HHS) community clinics 4. Has a working telephone number Exclusion Criteria: 1) None

Additional Information

Official title Implementation of an Automated EMR System to Connect Smokers in a Safety Net Healthcare System With Smoking Cessation Treatment
Principal investigator Lorna H. McNeill, PHD, MPH
Description Study Test: If you agree to take part in this study, you will collect a saliva sample to test for cotinine to confirm your smoking status. Cotinine is a chemical released in your body when it breaks down nicotine. You will receive a kit in the mail with supplies for the testing. The study staff will call you to make sure that you received the kit and to discuss the instructions with you. To collect the saliva, you will put a small piece of cotton in your mouth for a few minutes. You will mail the saliva sample back to the study staff, using a postage-paid envelope. Length of Study: Your participation in this study will be complete after you collect the saliva sample and mail it back to the study staff. Study data will be destroyed 5 years after the study has been completed and the data has been analyzed. Data collected in this study will not be used for future research. This is an investigational study. Up to 1,459 participants will be enrolled in this study. All will be enrolled at Harris Health System clinics.
Trial information was received from ClinicalTrials.gov and was last updated in July 2016.
Information provided to ClinicalTrials.gov by M.D. Anderson Cancer Center.